Search by Drug Name or NDC

NDC 59762-1308-04 Linezolid 100 mg/5mL Details

Linezolid 100 mg/5mL

Linezolid is a ORAL SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Greenstone LLC. The primary component is LINEZOLID.

MedlinePlus Drug Summary

Linezolid is used to treat infections, including pneumonia, and infections of the skin . Linezolid is in a class of antibacterials called oxazolidinones. It works by stopping the growth of bacteria. Antibiotics such as linezolid will not work for colds, flu, and other viral infections. Using antibiotics when they are not needed increases your risk of getting an infection later that resists antibiotic treatment.

Related Packages: 59762-1308-04
Last Updated: 04/28/2024
MedLinePlus Full Drug Details: Linezolid

Product Information

NDC	59762-1308
Product ID	59762-1308_eb2638f8-973d-4495-84ea-37e4a7553d86
Associated GPIs	16230040001920
GCN Sequence Number	045132
GCN Sequence Number Description	linezolid SUSP RECON 100 MG/5ML ORAL
HIC3	W1O
HIC3 Description	OXAZOLIDINONE ANTIBIOTICS
GCN	26871
HICL Sequence Number	021157
HICL Sequence Number Description	LINEZOLID
Brand/Generic	Generic
Proprietary Name	Linezolid
Proprietary Name Suffix	n/a
Non-Proprietary Name	linezolid
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	SUSPENSION
Route	ORAL
Active Ingredient Strength	100
Active Ingredient Units	mg/5mL
Substance Name	LINEZOLID
Labeler Name	Greenstone LLC
Pharmaceutical Class	Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]
DEA Schedule	n/a
Marketing Category	NDA AUTHORIZED GENERIC
Application Number	NDA021132
Listing Certified Through	2024-12-31

Package

NDC 59762-1308-04 (59762130804)

Pricing Information	N/A
NDC Package Code	59762-1308-4
Billing NDC	59762130804
Package	150 mL in 1 BOTTLE (59762-1308-4)
Marketing Start Date	2023-03-30
NDC Exclude Flag	N